Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses (Q42059101)

15 October 2017

Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses (English)

1 reference

Patricia Volkow-Fernández

15 October 2017

1 reference

2

object named as

Patricia Volkow-Fernández

1 reference

15 October 2017

Patricia Cornejo-Juárez

1

1 reference

15 October 2017

Kenia Escobedo-López

3

1 reference

15 October 2017

Diana Vilar-Compte

4

1 reference

15 October 2017

Guillermo Ruiz-Palacios

5

1 reference

15 October 2017

Luis Enrique Soto-Ramírez

6

1 reference

15 October 2017

6 April 2006

1 reference

AIDS Research and Therapy

15 October 2017

1 reference

15 October 2017

3

1 reference

15 October 2017

9

1 reference

Frontiers of occupational health. New vaccines, new prophylactic regimens, and management of the HIV-infected worker

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Diagnosis and treatment of hepatic disease in patients with HIV.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Reappearance of Hepatitis B Virus in Immune Patients Infected with the Human Immunodeficiency Virus Type 1

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Hepatitis B prevention and human immunodeficiency virus (HIV) infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Compromised B cell responses to influenza vaccination in HIV-infected individuals.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Hepatitis B and human immunodeficiency virus: Double trouble

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replication

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1468419

Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models

17 August 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

The frequency of lysosomal storage diseases in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Prevalence of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Enzyme replacement in a canine model of Hurler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Mucopolysaccharidosis in a Cat with Arylsulfatase B Deficiency: A Model of Maroteaux-Lamy Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

A step in the right direction: assessing exercise tolerance in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Pregnancies in Gaucher disease: a 5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.3.1.9

Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS

21 January 2018

1 reference

12 December 2020

Impaired response to recombinant hepatitis B vaccine in HIV-infected persons

1 reference

12 December 2020

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

12 December 2020

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

12 December 2020

Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV

1 reference

12 December 2020

Identifiers

DOI

10.2217/14750708.3.1.9

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

16600028

1 reference